Without naming the company, the company said it has secured a commercial licence for the intellectual property necessary to commercialize GLP-1 drugs – a class of highly effective diabetes and obesity drugs – following the expiry of the originator product patents.
Tag Archive for: Aspen Pharmacare
Announcing the deal on the sidelines of the United Nations General Assembly in New York, Novo said the contract will lead to the production of 16 million vials of insulin next year, marking its “expanded commitment” to improving access to life-saving insulin to people living with diabetes in Africa.